Esperion Therapeutics Inc (ESPR)

Oct 16, 2025

Esperion Nominates ESP-2001 as Preclinical Development Candidate for Treatment of Primary Sclerosing Cholangitis - GlobeNewswire

Oct 16, 2025

Oct 16, 2025

IND filing goal 2026: Esperion nominates ESP-2001 as preclinical PSC candidate, $1B market - Stock Titan

Oct 16, 2025

Oct 16, 2025

Will Esperion Therapeutics Inc. stock gain from lower inflation2025 Support & Resistance & Real-Time Stock Movement Alerts - newser.com

Oct 16, 2025

Oct 15, 2025

Published on: 2025-10-15 12:04:18 - newser.com

Oct 15, 2025

Oct 15, 2025

How to use Fibonacci retracement on Esperion Therapeutics Inc.Market Growth Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 15, 2025

Oct 15, 2025

Why Esperion Therapeutics Inc. stock is favored by top institutionsInsider Selling & Real-Time Stock Movement Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Why Esperion Therapeutics Inc. is moving todayWeekly Trade Review & Real-Time Stock Movement Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

How to integrate Esperion Therapeutics Inc. into portfolio analysis toolsJuly 2025 Trends & Real-Time Chart Breakout Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Esperion Therapeutics Inc. stock momentum explained2025 Geopolitical Influence & Low Risk High Reward Ideas - newser.com

Oct 15, 2025

Oct 15, 2025

How to use a screener to detect Esperion Therapeutics Inc. breakoutsPortfolio Gains Report & Proven Capital Preservation Methods - newser.com

Oct 15, 2025

Oct 15, 2025

Identifying reversal signals in Esperion Therapeutics Inc.July 2025 Opening Moves & Consistent Income Trade Ideas - newser.com

Oct 15, 2025

Oct 15, 2025

What’s the recovery path for long term holders of Esperion Therapeutics Inc.Trend Reversal & Safe Investment Capital Preservation Plans - newser.com

Oct 15, 2025

Oct 15, 2025

Will breakout in Esperion Therapeutics Inc. lead to full recovery2025 Performance Recap & Risk Managed Trade Strategies - newser.com

Oct 15, 2025

Oct 14, 2025

Esperion Therapeutics Inc. (ESPR) Stock Price | Live Quotes & Charts | NSD - StocksToTrade

Oct 14, 2025

Oct 14, 2025

Why analysts remain bullish on Esperion Therapeutics Inc. stockQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com

Oct 14, 2025

Oct 13, 2025

Analyzing drawdowns of Esperion Therapeutics Inc. with statistical toolsJuly 2025 Breakouts & Verified Entry Point Signals - newser.com

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 11:11:10 - newser.com

Oct 13, 2025

Oct 13, 2025

What analysts say about MarketAxess Holdings Inc stockMarket Liquidity Analysis & Rapid Portfolio Expansion - earlytimes.in

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 10:12:04 - newser.com

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 10:10:18 - newser.com

Oct 13, 2025

Oct 13, 2025

Can Esperion Therapeutics Inc. stock reach $100 price targetEarnings Beat & AI Enhanced Trading Signals - newser.com

Oct 13, 2025

Oct 13, 2025

How strong is Esperion Therapeutics Inc. stock balance sheet2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025

Oct 12, 2025

Esperion settles patent dispute with Dr. Reddy’s over cholesterol drugs - MSN

Oct 12, 2025

Oct 11, 2025

Esperion Therapeutics (ESPR): Assessing Valuation After $75 Million Discounted Stock Offering and Share Price Drop - Yahoo Finance

Oct 11, 2025

Oct 10, 2025

Will Esperion Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Why Esperion Therapeutics (ESPR) Is Up After $75M Equity Raise and Generic Settlement News - Yahoo Finance

Oct 10, 2025

Oct 10, 2025

How currency fluctuations impact Esperion Therapeutics Inc. stockTake Profit & Fast Momentum Entry Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Why Is Esperion Therapeutics Stock Sinking Premarket Today? - Stocktwits

Oct 10, 2025

Oct 10, 2025

Is Esperion Therapeutics Inc. stock attractive for hedge fundsJuly 2025 Selloffs & Safe Entry Point Identification - newser.com

Oct 10, 2025

Oct 10, 2025

ESPR- Japanese Drug Approval, Otsuka Payments to Help this Biotech Play - Yahoo Finance

Oct 10, 2025

Oct 10, 2025

(10/10/25) ESPR: Japanese Drug Approval, Otsuka Payments to Help this Biote - moneyshow.com

Oct 10, 2025

Oct 09, 2025

ESPR Stock Drops 17% on Pricing of $75M Common Stock Offering - sharewise.com

Oct 09, 2025

Oct 09, 2025

Is Esperion Therapeutics Inc. stock a buy on dips2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com

Oct 09, 2025

Oct 09, 2025

Published on: 2025-10-09 02:49:28 - newser.com

Oct 09, 2025

Oct 09, 2025

Esperion Therapeutics (NASDAQ:ESPR) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

Esperion Announces Public Offering to Raise $70.2 Million - TipRanks

Oct 08, 2025

Oct 08, 2025

Esperion Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since December 2024 -- Data Talk - 富途牛牛

Oct 08, 2025